The key representative, MCP-1/CCL2, has previously been demonstrated to be upregulated in CRC at the local [21,22] and systemic levels [30] and induce the proliferation [31] and epithelial-mesenchymal transition of tumor cells [19]. The gene discussed is CCL2; the disease is neoplasm.